Cancer Research The Future of Cancer Research: Science and Patient Impact  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 32, 254-258, February 1, 1972]
© 1972 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Janss, D. H.
Right arrow Articles by Irving, C. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Janss, D. H.
Right arrow Articles by Irving, C. C.

The Binding of 7,12-Dimethylbenz(a)anthracene to Mammary Parenchyma DNA and Protein in Vivo1

Douglas H. Janss, Richard C. Moon and Charles C. Irving

Veterans Administration Hospital, Memphis 38104 [D. H. J., C. C. I.], and Department of Physiology and Biophysics [D. H. J., R. C. M.], and Department of Biochemistry [D. H. J., C. C. I.], University of Tennessee, Memphis, Tennessee 38103

Sprague-Dawley female rats were sacrificed at various times after the intragastric administration of 7,12-dimethylbenz(a)anthracene (DMBA)-3H. The abdominal-inguinal mammary glands were removed, and the parenchymal cells were separated. Parenchymal cell DNA and protein were isolated, and the DNA was purified by density equilibrium centrifugation in cesium chloride. Sixteen hr after carcinogen feeding, DMBA binding amounted to 47 pmoles/mg of DNA. Fifty % of the DMBA bound to DNA at 16 hr was present 14 days after administration, and 31% was still detectable at 42 days. The amount of DMBA binding to protein was less than one-half that observed bound to DNA. Furthermore, by 14 days, DMBA binding to protein had declined to just detectable levels. Increased parenchymal cell DNA content, due to cellular proliferation resulting from DMBA-induced tumorigenesis, was not responsible for the decreased DNA specific activity observed at 14 and 42 days. Thus, persistent binding of DMBA to rat mammary parenchymal cell DNA in vivo was demonstrated.

1 Supported by the United states Veterans Administration and by USPHS Grants CA 05490 and CA 12630 from the National Cancer Institute.

Received 7/26/71. Accepted 10/ 7/71.




This article has been cited by other articles:


Home page
Toxicol SciHome page
T. L. Weimer, A. P. Reddy, U. Harttig, D. Alexander, S. C. Stamm, M. R. Miller, W. Baird, J. Hendricks, and G. Bailey
Influence of {beta}-Naphthoflavone on 7,12-Dimethylbenz(a)anthracene Metabolism, DNA Adduction, and Tumorigenicity in Rainbow Trout
Toxicol. Sci., October 1, 2000; 57(2): 217 - 228.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. Izzotti, A. Camoirano, C. Cartiglia, C. J. Grubbs, R. A. Lubet, G. J. Kelloff, and S. D. Flora
Patterns of DNA Adduct Formation in Liver and Mammary Epithelial Cells of Rats Treated with 7,12-Dimethylbenz(a)anthracene, and Selective Effects of Chemopreventive Agents
Cancer Res., September 1, 1999; 59(17): 4285 - 4290.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1972 by the American Association for Cancer Research.